13-Jul-2011 - Lonza Group Ltd

Lonza to acquire Arch Chemicals

Lonza Group Ltd and Arch Chemicals, Inc. announced that they have signed an agreement pursuant to which Lonza has agreed to commence a tender offer for 100 percent of Arch Chemicals’ outstanding shares of common stock at a price of USD 47.20 per share in cash.

Lonza’s offer represents a 36.7% premium to Arch Chemicals’ average closing price over the last 30 trading days. Based on the offer price for all the outstanding shares, Arch Chemicals’ enterprise value would be USD 1.4 billion (approximately CHF 1.25 billion).

Lonza’s cash offer is subject to customary conditions including the tendering of more than two-thirds of Arch Chemicals’ outstanding shares of common stock and clearance from antitrust regulatory authorities. Lonza expects to commence the tender offer by 15 July 2011 and to complete the tender offer later in 2011.

Stefan Borgas, CEO of Lonza, said: “This transaction represents an excellent strategic and cultural fit. Lonza and Arch Chemicals offer highly complementary products and technologies and together will be the global leader in controlling unwanted microbes. The business will enjoy a strong platform for accelerated future growth for the benefit of all our stakeholders.”

Upon completion of the transaction, Lonza will have the world’s leading microbial control business with 2010 pro-forma sales in this life science market of approximately USD 1.6 billion, combining the complementary product solutions of both companies.

Microbial Control – a global growth opportunity

The global microbial control market is currently valued at approximately USD 10 billion, and is growing at approximately 4-6% per annum. The key end-use segments of the market -- water treatment, hygiene, materials protection and personal care -- are growing at faster rates. The largest markets are North America, Europe and Japan. The fastest growing microbial control markets are Brazil, India, China and South Africa.

Facts, background information, dossiers
  • Lonza
  • Arch
More about Lonza
  • News

    Lonza Starts 2017 with Outstanding First Quarter

    During the first quarter of 2017, Lonza achieved another record quarter in terms of sales and earnings. The healthy overall company performance resulted from particularly strong performance in the Pharma&Biotech segment and continued robust growth in the Specialty Ingredients segment. “Foll ... more

    Lonza reports strong Q3 momentum

    Lonza recorded another strong quarter in terms of sales and earnings. The overall company results were a consequence of continued good performance in both the Specialty Ingredients and the Pharma&Biotech segments. “We have experienced a continuous growth pattern, which is further proof that ... more

    Lonza Acquires Chemical Company Zelam Based in New Zealand

    Lonza announced that it has acquired Zelam, a research-focused chemical company based in New Zealand, which develops and manufactures products for crop protection, specializing in fungicides, insecticides, herbicides, foliar nutrients and additives. Zelam also develops and manufactures prod ... more

  • Companies

    Lonza Ltd.

    Lonza continues to leverage its core strengths in innovation, technology, and regulatory expertise while capturing cross-divisional synergies in manufacturing, research, and sales. By clicking the Factsheet will find a detailed breakdown of our management committees, business divisions, gro ... more

    Lonza Verviers, S.p.r.l.

    more

    Lonza Ibérica SA

    Lonza Ibérica is responsible for the sales and market development of Fine Chemicals, Biocides, Vitamines and other Exclusive products cGMP or not in Spain and Portugal. Moreover, some of our business is in the area of Custom Synthesis for Life Science companies. Lonza Ibérica works as our c ... more

More about Arch
  • News

    Lonza extends tender offer for all outstanding shares of Arch Chemicals common stock

    Lonza Group Ltd announced that LG Acquisition Corp., an indirect wholly owned subsidiary of Lonza, has extended the expiration date for its previously announced tender offer for 100 percent of the outstanding shares of common stock of Arch Chemicals, Inc.. The tender offer is at a price of ... more

    Arch Chemicals Hires Dr. Alex Valcke as Vice President, Innovation

    Dr. Alex Valcke will be joining Arch Chemicals as Vice President, Innovation, effective November 1, 2009 and reporting to Arch Chairman, President and CEO Michael E. Campbell. In this capacity, he will work closely with Arch’s senior management team and its businesses to ensure that Arch is ... more

    Arch Chemicals Announces Departure of Chief Operating Officer

    Arch Chemicals, Inc. announced that Louis S. Massimo, Arch Chemicals’ Executive Vice President and Chief Operating Officer, will be leaving the Company to pursue other opportunities. The Company will reassign Mr. Massimo’s responsibilities within its senior management team and will announc ... more

  • Companies

    Arch Química, S.A. de C.V.

    Innovative, Chemistry-based Solutions Driving Profitable, Global Growth Headquartered in Norwalk, Connecticut (USA), Arch Chemicals, Inc. is a global Biocides company with approximately $1.5 billion in annual sales. Together with our subsidiaries, we have 3,000 employees and manufacturing ... more

    Arch Sayerlack Coatings S.r.l.

    Founded in 1954 Sayerlack set itself the goal of producing the best possible wood coatings that advanced technology could formulate. With this aim Sayerlack quickly became one of the leaders in the wood coatings industry increasing its production volumes from 50 tons in 1954 to 44517 tons i ... more